These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37169037)

  • 1. The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein.
    Angeloni E; Germelli L; Marchetti L; Da Pozzo E; Tremolanti C; Wetzel CH; Baglini E; Taliani S; Da Settimo F; Martini C; Costa B
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166751. PubMed ID: 37169037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo Neurosteroidogenesis in Human Microglia: Involvement of the 18 kDa Translocator Protein.
    Germelli L; Da Pozzo E; Giacomelli C; Tremolanti C; Marchetti L; Wetzel CH; Barresi E; Taliani S; Da Settimo F; Martini C; Costa B
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human oligodendrocyte-like cell differentiation is promoted by TSPO-mediated endogenous steroidogenesis.
    Tremolanti C; Angeloni E; Da Pozzo E; Germelli L; Giacomelli C; Scalzi E; Taliani S; Da Settimo F; Mensah-Nyagan AG; Martini C; Costa B
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167174. PubMed ID: 38631406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial Pro-Inflammatory and Anti-Inflammatory Phenotypes Are Modulated by Translocator Protein Activation.
    Pozzo ED; Tremolanti C; Costa B; Giacomelli C; Milenkovic VM; Bader S; Wetzel CH; Rupprecht R; Taliani S; Settimo FD; Martini C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis.
    Karlstetter M; Nothdurfter C; Aslanidis A; Moeller K; Horn F; Scholz R; Neumann H; Weber BH; Rupprecht R; Langmann T
    J Neuroinflammation; 2014 Jan; 11():3. PubMed ID: 24397957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocator protein (18 kDa) regulates the microglial phenotype in Parkinson's disease through P47.
    Xue X; Duan R; Zheng G; Chen H; Zhang W; Shi L
    Bioengineered; 2022 Apr; 13(4):11061-11071. PubMed ID: 35475466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
    Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.
    Cosenza-Nashat M; Zhao ML; Suh HS; Morgan J; Natividad R; Morgello S; Lee SC
    Neuropathol Appl Neurobiol; 2009 Jun; 35(3):306-28. PubMed ID: 19077109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines.
    Wolf L; Bauer A; Melchner D; Hallof-Buestrich H; Stoertebecker P; Haen E; Kreutz M; Sarubin N; Milenkovic VM; Wetzel CH; Rupprecht R; Nothdurfter C
    Pharmacopsychiatry; 2015 Mar; 48(2):72-7. PubMed ID: 25654303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.
    Nothdurfter C; Baghai TC; Schüle C; Rupprecht R
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S107-12. PubMed ID: 22923187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9 Mediated TSPO Gene Knockout alters Respiration and Cellular Metabolism in Human Primary Microglia Cells.
    Milenkovic VM; Slim D; Bader S; Koch V; Heinl ES; Alvarez-Carbonell D; Nothdurfter C; Rupprecht R; Wetzel CH
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocator Protein 18-kDa: A Promising Target to Treat Neuroinflammation- related Degenerative Diseases.
    Tremolanti C; Germelli L; Barresi E; Da Pozzo E; Simorini F; Castellano S; Taliani S; Da Settimo F; Martini C; Costa B
    Curr Med Chem; 2022 Aug; 29(28):4831-4861. PubMed ID: 35430971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 18 kDa translocator protein, microglia and neuroinflammation.
    Liu GJ; Middleton RJ; Hatty CR; Kam WW; Chan R; Pham T; Harrison-Brown M; Dodson E; Veale K; Banati RB
    Brain Pathol; 2014 Nov; 24(6):631-53. PubMed ID: 25345894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease.
    Vicente-Rodríguez M; Mancuso R; Peris-Yague A; Simmons C; ; Gómez-Nicola D; Perry VH; Turkheimer F; Lovestone S; Parker CA; Cash D
    J Neuroinflammation; 2023 Apr; 20(1):92. PubMed ID: 37032328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.
    Nothdurfter C; Rammes G; Baghai TC; Schüle C; Schumacher M; Papadopoulos V; Rupprecht R
    J Neuroendocrinol; 2012 Jan; 24(1):82-92. PubMed ID: 21609361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial translocator protein and stressor-related disorder.
    Kikutani K; Giga H; Hosokawa K; Shime N; Aizawa H
    Neurochem Int; 2020 Nov; 140():104855. PubMed ID: 32980493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ligands of Translocator Protein: Design and Biological Properties.
    Mokrov GV; Deeva OA; Gudasheva TA
    Curr Pharm Des; 2021; 27(2):217-237. PubMed ID: 32881658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Expression of Translocator Protein (TSPO) Marks Pro-inflammatory Microglia but Does Not Predict Neurodegeneration.
    Beckers L; Ory D; Geric I; Declercq L; Koole M; Kassiou M; Bormans G; Baes M
    Mol Imaging Biol; 2018 Feb; 20(1):94-102. PubMed ID: 28695372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
    Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
    Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.